Measure of HIV/STD risk-reduction: strategies for enhancing the utility of behavioral and biological outcome measures for African American couples.

Journal of Acquired Immune Deficiency Syndromes : JAIDS
NIMH Multisite HIV/STD Prevention Trial for African American Couples Group

Abstract

Numerous studies have discussed the value of including biological outcome measures as a complement to behavioral outcome measures to assess the efficacy of HIV risk-reduction interventions. This article highlights strategies used to minimize the limitations of including both self-reported sexual behaviors and biologically confirmed sexually transmitted diseases as primary outcome measures in an HIV/sexually transmitted disease (STD) prevention program for African American serodiscordant couples (Eban). Couples receiving an HIV intervention condition (Eban) were compared with couples receiving a time-equivalent General Health Promotion condition on behavioral and biological outcomes. Both behavioral and biological data were collected at baseline, immediately postintervention, and at 6 and 12 months postintervention. Literature reviews, consulting other researchers who conducted couples studies, our investigative team's experience in previous HIV interventions, and formative work were used to develop procedures to minimize potential limitations associated with the inclusion of behavioral and biological outcome measures for Eban. Given the strengths of including behavioral and biological outcome measures, the Eban study chose to h...Continue Reading

References

Nov 6, 1991·JAMA : the Journal of the American Medical Association·D L HigginsR Johnson
Aug 1, 1990·American Journal of Public Health·N S Padian
May 1, 1995·Sexually Transmitted Diseases·N S PadianG Bolan
Jan 1, 1995·Sexually Transmitted Diseases·J M ZenilmanD Celentano
Jan 1, 1997·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·D P Orr
May 1, 1997·Sexually Transmitted Diseases·D P OrrM J Blythe
Oct 2, 1998·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·L S WeinhardtS M Wickramasinghe
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S Cu-UvinK H Mayer
Feb 17, 2000·Sexually Transmitted Diseases·M Fishbein, W Pequegnat
Mar 1, 2000·American Journal of Epidemiology·L W DickerS M Berman
Nov 6, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·K BuchaczN Padian
Mar 2, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Toye Helena BrewerJonathon M Zenilman
Sep 10, 2002·Sexually Transmitted Diseases·Sevgi O Aral, Thomas A Peterman
Dec 11, 2002·Sexually Transmitted Infections·R J DiClementeR A Crosby
May 3, 2003·American Journal of Preventive Medicine·Richard CrosbyCynthia A Graham
May 30, 2003·American Journal of Public Health·Nabila El-BasselPeter Steinglass
Jul 29, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C PollaraN Manca
Aug 1, 1960·Journal of Consulting Psychology·D P CROWNE, D MARLOWE
Dec 4, 2003·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Nancy D BrenerWilliam R Grady
Jul 2, 2004·International Journal of STD & AIDS·William L YarberRichard A Crosby
Jul 14, 2004·JAMA : the Journal of the American Medical Association·Ralph J DiClementeAlyssa Robillard
Jun 9, 2005·Archives of Pediatrics & Adolescent Medicine·Gabriela Paz-BaileyLauri E Markowitz
Jul 12, 2005·American Journal of Health Behavior·Diane M GrimleyHuey Chen
Aug 30, 2005·Infectious Diseases in Obstetrics and Gynecology·A M CaliendoG M Wingood
Mar 3, 2006·AIDS·Nicole CrepazUNKNOWN HIV/AIDS Prevention Research Synthesis (PRS) Team
Dec 13, 2006·AIDS·Rosemary Dray-SpiraUNKNOWN VESPA Study Group
Apr 7, 2007·AIDS·UNKNOWN NIMH Collaborative HIV/STD Prevention Trial Group

❮ Previous
Next ❯

Citations

May 26, 2010·AIDS and Behavior·UNKNOWN NIMH Multisite HIV/STD Prevention Trial for African American Couples Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.